Lateral flow assay modified with time-delay wax barriers as a sensitivity and signal enhancement strategy by Sena Torralba, Amadeo et al.
This is the submitted version of the following article:
Sena-Torralba A., Ngo D.B., Parolo C., Hu L., Álvarez-Diduk
R., Bergua J.F., Rosati G., Surareungchai W., Merkoçi A..
Lateral flow assay modified with time-delay wax barriers as a
sensitivity and signal enhancement strategy. Biosensors and
Bioelectronics, (2020). 168. 112559: - .
10.1016/j.bios.2020.112559,
which has been published in final form at
https://dx.doi.org/10.1016/j.bios.2020.112559 ©
https://dx.doi.org/10.1016/j.bios.2020.112559. This
manuscript version is made available under the CC-BY-NC-ND
4.0 license
http://creativecommons.org/licenses/by-nc-nd/4.0/
Lateral flow assay modified with time-delay wax barriers as a 1 
sensitivity and signal enhancement strategy.  2 
 3 
Amadeo Sena-Torralba a†, Duy Ba Ngo b†, Claudio Parolo a, Liming Hu a, Ruslan Álvarez a, 4 
Jose Francisco Bergua a, Giulio Rosati a, Werasak Surareungchai b d and Arben Merkoçi a c* 5 
 6 
a. Nanobioelectronics & Biosensors Group, Institut Català de Nanociència i Nanotecnologia (ICN2), CSIC and 7 
The Barcelona Institute of Science and Technology (BIST), Campus UAB, 08193, Bellaterra, Barcelona, Spain. 8 
b. School of Bioresoures and Technology, King Mongkut’s University of Technology Thonburi (KMUTT), 9 
Bangkok 10150, Thailand. 10 
c. Catalan Institution for Research and Advanced Studies (ICREA), Pg. Lluís Companys 23, 08010 Barcelona, 11 
Spain. 12 
d. Nanoscience and Nanotechnology Graduate Research Program, Faculty of Science, KMUTT, Bangkok 10140, 13 
Thailand 14 
 15 
* arben.merkoci@icn2.cat 16 
† Amadeo Sena-Torralba and Duy Ba Ngo contributed equally to this work.  17 
 18 






The ease of use, low cost and quick operation of lateral flow assays (LFA) have made them 25 
some of the most common point of care biosensors in a variety of field. However, their 26 
generally low sensitivity has limited their use for more challenging applications, where 27 
the detection of low analytic concentrations is required. Here we propose the use of 28 
soluble wax barriers to selectively and temporarily accumulate the target and label 29 
nanoparticles on top of the test line (TL). This extended internal incubation step 30 
promotes the formation of the immune-complex, generating a 2.8-fold sensitivity 31 
enhancement and up to 96% signal enhancement compared to the conventional LFA for 32 
Human IgG (H-IgG) detection. 33 
 34 
1. Introduction 35 
During the last decade we have been observing an ever-growing need for fast and reliable 36 
sensing devices for healthcare, environmental and safety applications.(Turner, 2013, 37 
Malhotra et al., 2005) Both developed and developing countries are increasingly relying 38 
on the use of point of care tests (POCT) to keep up with the saturation of their health-care 39 
systems, to monitor the quality of their environmental resources and to prevent possible 40 
threats. The POCTs represent not only convenient analytical tools for rural regions (they 41 
are cheap, portable and easy to use), but they are also establishing themselves as key 42 
monitoring devices in the busy centralized areas.(Price, 2001,  Land et al., 2019, Chin et 43 
al., 2012) For example a faster diagnosis means faster therapy initiation and higher 44 
chances to control the spread of a disease; and it also means a quicker response time for 45 
starting a remediation campaign in a contaminated river. In this context LFAs are 46 
probably the most used POCT covering the widest variety of applications.(Quesada-47 
González and Merkoçi, 2015, Posthuma-Trumpie et al., 2009) They serve as an excellent 48 
tool for healthcare,(Chen et al., 2016, Brangel et al., 2018) safety(Quesada-González et al., 49 
2018, Mirasoli et al., 2012) and environmental applications(Hassan et al., 2019,  50 
Schubert-Ullrich et al., 2009,  Raeisossadati et al., 2016). 51 
Being fast and easy to use are key features for the POCTs, but they also come with the 52 
drawback that the sensitivity of the POCTs has no match with laboratory-based, slower, 53 
multi-steps sensing techniques. For example in the LFA the binding event between bio-54 
receptors (antibodies, aptamers) and their targets happens in the order of seconds (the 55 
time required for the flow to pass the TL)(Gasperino et al., 2018, Miller et al., 2018), while 56 
in Enzyme-Linked Immunosorbent Assays (ELISA)(Van Weemen and Schuurs, 1971) 57 
incubation for several hours is common. Although for many applications the sensitivity 58 
of LFAs is sufficient, finding a way to improve it without affecting their being the POC 59 
would open a plethora of new applications. Here we are describing just that, a method to 60 
increase the time of the bio-recognition event, without affecting the ease of use and the 61 
overall sensing time of the LFAs.  62 
The concept at the base of LFAs, is the use of capillary movement to guide the sample 63 
through different functional membranes.(Quesada-González and Merkoçi, 2015,  64 
Muhammad Sajid et al., 2015) Taking as example an immune-sandwich (non-65 
competitive) assay, first the sample encounters the sample pad, where pre-stored 66 
biochemical reagents stabilizes its pH and ionic strength at their optimal values to 67 
maximize the signal to noise ratio.(Millipore, 2013) Then it flows to the conjugate pad, 68 
where the detection antibodies (generally labelled with coloured nanoparticles) 69 
recognize the target in the first bio-recognition event.(Quesada-González et al., 2019) 70 
Then the solution flows along the detection pad, where the complex target/labelled-71 
antibody binds to the capture antibodies of the TL, during the second bio-recognition 72 
event. Finally the sample after passing through the control line (CL), reaches the 73 
absorbent pad at the end of the LFA. Surprisingly most of the reported works trying to 74 
improve the sensitivity of LFA have focused on increasing the time for the first bio-75 
recognition event, but depending on the flow-rate of the pads it can already take minutes. 76 
(Zhang et al., 2019,  Tsai et al., 2018) Instead of the second bio-recognition event is always 77 
in the order of seconds, representing the real bottle neck for the sensitivity of the test.  78 
The possibility to slow down or even temporarily stop the flow above the test line would 79 
increase the time for both bio-recognition events, boosting the sensitivity of the LFAs. 80 
Here we present how we achieved it by placing a soluble wax barrier 1 mm after the TL. 81 
Looking at previous works we find that wax structures were previously employed in LFAs 82 
just to control the flow (Giokas et al., 2014, Lai et al., 2019, Phillips et al., 2016, Rivas et 83 
al., 2014), but never to temporarily stop it. While some paper-based microfluidic devices 84 
did incorporate real barrier to achieve incubation steps, but they were introduced before 85 
the test line and were based on salt (He et al., 2019) or sugar(Lutz B, Liang T, Fu E, 86 
Ramachandran S, Kauffman P, 2013), which once dissolved can affect the ionic strength 87 
of the working buffer and thus the binding reaction. Instead, here, the wax barrier is 88 
printed on the surface of the nitrocellulose membrane and melted in order to assure its 89 
penetration through the membrane pores creating a hydrophobic barrier just after the 90 
TL, which is the place where the second bio-recognition event is taking place. The 91 
conjugate solution together with the sample solution flows along the nitrocellulose 92 
membrane towards the test line, giving time for the first binding event to occur. Once 93 
arrived to wax barrier, the solution stops temporarily on top of the test line until the 94 
barrier breaks due to the surfactant present on the strip (figure 1). In this sense, the 95 
thickness of the wax barrier and the concentration of surfactant can be carefully selected 96 





Figure 1. Schematic representation of the proposed strategy for the detection of H-IgG. 102 
(A) In the standard LFA the flow is constantly moving towards the absorbent pad and the 103 
bio-recognition event occurs within seconds. Few labelled antibodies are captured in TL, 104 
thus the signal intensity is weak. (B) In the LFA modified with a wax barrier, the flow is 105 
temporarily stopped on the TL. This increases the time for the bio-recognition event and 106 
boosts the assay’s sensitivity. (C) Fluorescent microscope pictures (40X) of the wax 107 
barrier on the LFA strip. The wax barrier temporarily retains the solution. Once broken 108 
by the Tween-20, the solution goes through the barrier.   109 
 110 
2. Experimental section 111 
2.1. Materials and reagents 112 
Goat anti-human IgG antibody, human IgG, bovine serum albumin (BSA), 113 
Tetrachloroauric acid (HAuCl4), trisodium citrate, phosphate buffer saline (PBS) tablets, 114 
sodium phosphate basic and dibasic, sodium tetraborate, boric acid sucrose and Tween 115 
20 were purchased from Sigma Aldrich. Chicken anti-goat antibody was purchased from 116 
Abcam. Nitrocellulose membranes (CN95 and CN150) were purchased from Sartorius 117 
Stediem and CNPF200 from mdi. Cellulose membrane (CFSP001700) was purchased in 118 
Merck Millipore, glass fiber (Standard14) from GE Healthcare and supporting adhesive 119 
cards were purchased from Kenosha. Decol food colorant red powder was purchased in 120 
Torten Deko and wax ink (Xerox 108R00935 black) was purchased in Xerox.  121 
2.2. Instruments 122 
Wax printer Xerox ColorQube 8580, Bioreagent dispenser (Imagene Technology), 123 
Microscope Olympus cellSense, Centrifuge Allegra 64R, Lateral flow strips cutter 124 
(Shanghai Kinbio Tech), Spectrophotometer SpectraMax ID3, SkanMulti (Skannex), TEM 125 
Technai F20.  126 
2.3. Synthesis and characterization of gold nanoparticles  127 
The gold nanoparticles (AuNPs) were synthesized following the Turkevich 128 
method(Turkevich et al., 1951) and were characterized with TEM (~ 15 nm) and 129 
spectrophotometer (absorbance peak at 515 nm) (figure S1 and S2), respectively. The 130 
AuNPs were adjusted to pH 9.2 using borate buffer (10 mM pH 9.2) and centrifuged at 131 
14000 rpm for 30 minutes. Finally, they were re-suspended in 250 μL of PBS (10 mM, pH 132 
7.4, 5% sucrose, 1% BSA and 0.5% tween-20) and dried in the glass fiber overnight. 133 
Moreover, the sample pad was blocked with PBS (10 mM, pH 7.4, 0.5% BSA and 0.05% to 134 
0.1% tween-20) and dried overnight. 135 
2.4. Conjugation of the AuNPs with anti H-IgG 136 
The AuNPs were conjugated to antibodies against H-IgG following the procedure 137 
previously reported by our group.(Ambrosi et al., 2007) In order to check if the AuNPs 138 
were successfully conjugated with the antibodies, the absorbance spectrum was 139 
evaluated. As observed in figure S2, the maximum absorbance peak of the conjugated the 140 
AuNPs has a little red shift (about 5 nm), indicating the presence of the antibodies on the 141 
surface of the AuNPs.  142 
 143 
3. Results and discussion 144 
3.1. Evaluation of the retention time  145 
When developing the POCT, reproducibility is one of the most important parameters to 146 
optimize. For this reason, we fixed the lateral flow strip dimensions to 6 x 0.3 cm and 147 
verified that the bed volume corresponds to 70 µL (figure S3). We then proceeded to 148 
optimize the barrier fabrication by printing black lines with different widths (0.01, 0.03, 149 
0.05 y 0.1 mm) onto CN95 nitrocellulose membrane, and melting homogeneously the wax 150 
at 95 ° C for 5 minutes in the oven (figure S4). Next, we evaluated the time required for 151 
breaking the barriers at different concentrations of Tween-20, following the former 152 
optimized parameters. In particular, we fabricated lateral flow strips containing different 153 
concentrations of Tween-20 (0.05%, 0.1%, 0.5% and 0.1%) in the sample pad and the 154 
AuNPs in the conjugate pad. The retention time was measured from the moment at which 155 
the AuNPs reached the wax barrier until they crossed the barrier.  156 
 157 
As a result, we generated a matrix providing the wax barrier width and Tween-20 158 
concentration that provide different retention times (Table 1 and figure S5). As expected, 159 
the retention time increases increasing barrier width and decreasing Tween-20 160 
concentration. In particular, we achieved the longest retention time (12 minutes) by 161 
employing barriers of 0.05 mm and a concentration of Tween-20 of 0.1%; while the 162 
shortest retention time (1 minute) required a barrier width of 0.01 mm and 0.5% Tween-163 
20. Width of 0.1 mm and Tween-20 concentration of 0.05%, showed to be not suitable for 164 
the assay as the barriers broke once the AuNPs solution was already dried out.  165 
 166 
Moreover, we printed the barriers in a slower flow rate nitrocellulose membrane 167 
(CNPF200 mdi), in order to evaluate how the use of smaller pore sizes can affect the 168 
retention time. In this case, the pressure applied by the wax printing process compacted 169 
the pore of the nitrocellulose, thereby the flow could not even reach the TL. 170 
 171 
Table 1. Retention times on CN95 with different wax barrier width and %Tween-20  172 
Wax width (mm) 0.5% Tween-20  0.1% Tween-20  0.05% Tween-20  
0.01  1.40 ± 0.42 min 3.93 ± 1.55 min NB 
0.03 2.25 ± 0.13 min 7.64 ± 1.19 min NB 
0.05 7.23 ± 0.86 min 11.45 ± 1.33 min NB 
0.10 NB NB NB 
* NB: No Breaking, which means that the solution dried out before breaking the wax barrier. 173 
 174 
3.2. Evaluation of the sensitivity enhancement in LFA  175 
Finally, after determining the optimum conditions to achieve the longest flow retention, 176 
we performed the lateral flow immunoassay for H-IgG detection. In order to check if there 177 
is a correlation between the retention time on the TL and the sensitivity enhancement, 178 
we fabricated the strips without barriers and with barriers width of 0.01, 0.03 and 0.05 179 
mm. In this regard, we used CN95 and 0.1% Tween-20 as surfactant to break the barriers. 180 
We were expecting to see a progressive sensitivity enhancement when using higher 181 
width barriers, obtaining the highest sensitivity by using 0.05 mm width barrier, since 182 
this is the one that provides the longest retention time. Next, we prepared the strips by 183 
fixing anti H-IgG antibodies (1 mg mL-1) in the TL and anti-goat antibodies (1 mg mL-1) in 184 
the CL, both in 10 mM PB buffer pH 7.4. Moreover, we conjugated the AuNPs with anti H-185 
IgG by following the procedure previously reported by our group,(Ambrosi et al., 2007) 186 
explained in the experimental section. Furthermore, we performed calibration curves 187 
using serial dilutions of H-IgG (0 ng mL-1 to 103 ng mL-1). Finally, we evaluated the signal 188 
intensity in both the TL and CL the by taking a picture of the strips using a LFA scanner 189 
and analyzing them with Image J software.(Schneider et al., 2012) We took the pictures 190 
of the strips once the AuNPs solution had completely reached the absorbent pad. 191 
Eventually, we used the signal values of the TL and the CL after background signal 192 
subtraction, and normalized the signal value by dividing TL over CL.  193 
 194 
Figure S6 shows the calibration curves obtained when using CN95 and CN150 without 195 
the barriers and CN95 with 0.01, 0.03 and 0.05 mm width barriers. As observed the 196 
normalized optical density increases upon the detection of higher concentrations of H-197 
IgG.  Figure S7 shows the pictures of the lateral flow strips after performing the assays. 198 
In order to evaluate the sensitivities obtained with each condition we performed a linear 199 
fitting from 10 to 1000 ng mL-1 and we considered the slope values (figure 2A). As we 200 
were expecting, a higher sensitivity is achieved when using wider barriers, as this assures 201 
a longer interaction time between the antibodies in TL, AuNPs and the analyte. The 202 
highest sensitivity is achieved when using a 0.05 mm width barrier, which provides a 2.8-203 
fold enhancement compared to the same nitrocellulose without barriers. It is noteworthy 204 
that, conversely to the reported, there isn’t an outstanding sensitivity improvement when 205 
reducing the flow rate by using a smaller pore nitrocellulose membrane, as in the case of 206 
CN150. (Millipore, 2013, NanoComposix, 2016) Besides, we have proved that the 207 
outstanding sensitivity enhancement is obtained only when temporarily stopping the 208 
flow above the TL.  209 
 210 
Moreover, we calculated the limit of detection (LoD) and quantification (LoQ) achieved 211 
for every tested condition. The LoD was calculated as 𝑂𝑝𝑡𝑖𝑐𝑎𝑙 𝑑𝑒𝑛𝑠𝑖𝑡𝑦𝐿𝑂𝐷 = 𝑏𝑙𝑎𝑛𝑘 +212 
3 𝜎𝑏𝑙𝑎𝑛𝑘 (i.e. the corresponding value of blank sample plus 3 times its standard deviation). 213 
(Armbruster and Pry, 2008) The LoD for CN95, CN150 and CN95 with 0.01, 0.03 and 0.05 214 
mm width barriers were 35.01, 73.23, 21.67, 18.71, 14.47 ng·mL-1, respectively. 215 
Furthermore, the LoQ, calculated as 𝑂𝑝𝑡𝑖𝑐𝑎𝑙 𝑑𝑒𝑛𝑠𝑖𝑡𝑦𝐿𝑂𝐷 = 𝑏𝑙𝑎𝑛𝑘 + 10 𝜎𝑏𝑙𝑎𝑛𝑘 , were 216 
2129.09, 1909.76, 1164.38, 87.49, 41.19 ng·mL-1, respectively. We obtained the lowest 217 
LoD and LoQ values by setting the barriers at the condition that permitted the highest 218 
retention time of the conjugate solution on the TL.  219 
 220 
In figure 2B, we show pictures of the LFA strips after performing the calibration curve 221 
assay from 10 to 1000 ng mL-1 using CN95, CN150 non-modified with the wax barriers 222 
and CN95 modified with 0.01, 0.03 and 0.05 mm width barriers. As observed, there is a 223 
signal enhancement in TL when introducing the wax barriers in to the system. The 224 
percentage signal enhancement was calculated taking as reference the normalized optical 225 
density of the strips with CN95 and without the wax barriers (Table S2). As observed, the 226 
percentage signal increase is higher for increasing concentrations of H-IgG. The highest 227 
percentage signal increase is 96%, and was achieved for 1000 ng mL-1 when using CN95 228 
with a 0.05 mm width barrier. 229 
 230 
Finally, we proved that a longer incubation time of the conjugate solution over the TL 231 
didn’t favor the generation of non-specific signal in TL. As shown in figure S7, the signal 232 
in TL for blank samples (0 ng mL-1 of H-IgG) is not higher when using wider wax barriers, 233 
as we obtained the highest TL signal for the blank sample when using the CN150 234 





Figure 2. The LFA for H-IgG detection using time-delay barriers. (A) Calibration curve 240 
from 10 to 1000 ng mL-1 showing the optical density linear range when using CN95 241 
(Optical density = 0.0631 ln [H-IgG (ng mL-1)] + 0.0433 r2=0.98) and CN150 non-modified 242 
with the wax barriers (Optical density = 0.0695 ln [H-IgG (ng mL-1)] + 0.0627 r2=0.99) 243 
and CN95 modified with 0.01 (Optical density = 0.0925 ln [H-IgG (ng mL-1)] + 0.0124 244 
r2=0.99), 0.03 (Optical density = 0.1359 ln [H-IgG (ng mL-1)] - 0.1165 r2=0.96) and 0.05 245 
mm width barriers (Optical density = 0.1767 ln [H-IgG (ng mL-1)] - 0.2056 r2=0.98). (B) 246 
Pictures of the LFA strips after performing the calibration curve assay from 10 to 1000 247 
ng mL-1 using CN95, CN150 non-modified with the wax barriers and CN95 modified with 248 
0.01, 0.03 and 0.05 mm width barriers.  249 
 250 
4. Conclusion 251 
In conclusion, we have developed a LFA modified with time-delay barriers as a strategy 252 
for sensitivity and signal enhancement. We have achieved an inner incubation time of 12 253 
minutes, which produced a 2.8-fold enhancement in sensitivity and up to 96% signal 254 
enhancement. We believe the proposed method represents an outstanding solution to 255 
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